PARVOVIRUS FORMULATION
European patent · EP3277299 · In force
Register entry
- Publication number
- EP3277299
- Application number
- EP16725045
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 3, 2016
- Published
- Feb 7, 2018
- Granted
- Sep 26, 2018
- Protection ends at the latest
- May 2, 2036
- Next annual fee due
- May 31, 2027
- IPC classes
- A61K 35/768 (2015.01)A61K 47/24 (2006.01)A61K 9/00 (2006.01)A61P 35/00 (2006.01)
- Priority
- EP 15173308 23.06.2015
- PCT application
- PCT/EP2016/059832 03.05.2016
- PCT publication
- WO2016/206844 29.12.2016
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 19, 2026
Next annual fee due on
- Next annual fee due on
- 31.05.2026 → 31.05.2027
Published in Swissreg on 19.10.2026
- Jun 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.05.2025 → 31.05.2026
Published in Swissreg on 01.06.2025
- Jun 2, 2024
Change
Published in Swissreg on 02.06.2024
- Jun 1, 2023
Change
Published in Swissreg on 01.06.2023
- Dec 12, 2018
Agent entered
- Representative
- Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano
Published in Swissreg on 12.12.2018
- Sep 26, 2018
Granted
Published in Swissreg on 26.09.2018
Parties
Holder
Inventor
81377 München, DE
69118 Heidelberg, DE
69121 Heidelberg, DE
69121 Heidelberg, DE
81677 München, DE
68526 Ladenburg, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.